THE BIOLOGICAL PHENOTYPE OF HIV-1 IS USUALLY RETAINED DURING AND AFTER SEXUAL TRANSMISSION

被引:64
作者
FIORE, JR
BJORNDAL, A
PEIPKE, KA
DISTEFANO, M
ANGARANO, G
PASTORE, G
GAINES, H
FENYO, EM
ALBERT, J
机构
[1] KAROLINSKA INST,SWEDISH INST INFECT DIS CONTROL,DEPT CLIN IMMUNOL,STOCKHOLM,SWEDEN
[2] KAROLINSKA INST,DEPT MICROBIOL & TUMORBIOL,STOCKHOLM,SWEDEN
[3] UNIV BARI,CTR INFECT DIS,BARI,ITALY
[4] KAROLINSKA INST,SWEDISH INST INFECT DIS,DEPT CLIN VIROL,STOCKHOLM,SWEDEN
关键词
D O I
10.1006/viro.1994.1534
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The biological phenotype of HIV-1 isolates from 21 subjects with primary HIV-1 infection was determined in primary lymphocytes and monocyte-derived macrophages as well as in three T-cell lines (MT-2, HUT78, and C8166). Seven isolates (33%) replicated on at least one cell line and were classified as rapid/high (n = 6) or intermediate (n = 1), while 14 isolates (67%) did not replicate in cell lines and were classified as slow/low. All isolates replicated in primary monocyte-derived macrophage cultures. Studies on 10 pairs consisting of index case and seroconverting sexual partner showed that the biological phenotype of HIV-1 was unchanged in nine transmissions, including 5 pairs where a rapid/high virus was transmitted. Most individuals (5 of 6) infected by a rapid/high virus retained this phenotype after seroconversion. These individuals also had significantly lower CD4 lymphocyte counts 1-3 years after infection. Thus, in contrast to what has been suggested by others, we found that HIV-1 variants with rapid/high phenotype were usually not suppressed, neither during sexual transmission nor after seroconversion in the new host. These findings have important implications for the understanding of HIV-1 transmission and pathogenesis as well as for vaccine design. (C) 1994 Academic Press, Inc.
引用
收藏
页码:297 / 303
页数:7
相关论文
共 38 条
[1]   ISOLATION OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) FROM PLASMA DURING PRIMARY HIV-INFECTION [J].
ALBERT, J ;
GAINES, H ;
SONNERBORG, A ;
NYSTROM, G ;
PEHRSON, PO ;
CHIODI, F ;
VONSYDOW, M ;
MOBERG, L ;
LIDMAN, K ;
CHRISTENSSON, B ;
ASJO, B ;
FENYO, EM .
JOURNAL OF MEDICAL VIROLOGY, 1987, 23 (01) :67-73
[2]  
ASIO B, 1986, LANCET, V1, P660
[3]  
BAUR A, 1989, LANCET, V2, P1045
[4]   VIRAL DETERMINANTS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 T-CELL OR MACROPHAGE TROPISM, CYTOPATHOGENICITY, AND CD4 ANTIGEN MODULATION [J].
CHENGMAYER, C ;
QUIROGA, M ;
TUNG, JW ;
DINA, D ;
LEVY, JA .
JOURNAL OF VIROLOGY, 1990, 64 (09) :4390-4398
[5]   BIOLOGIC FEATURES OF HIV-1 THAT CORRELATE WITH VIRULENCE IN THE HOST [J].
CHENGMAYER, C ;
SETO, D ;
TATENO, M ;
LEVY, JA .
SCIENCE, 1988, 240 (4848) :80-82
[6]   HIGH TITERS OF CYTOPATHIC VIRUS IN PLASMA OF PATIENTS WITH SYMPTOMATIC PRIMARY HIV-1 INFECTION [J].
CLARK, SJ ;
SAAG, MS ;
DECKER, WD ;
CAMPBELLHILL, S ;
ROBERSON, JL ;
VELDKAMP, PJ ;
KAPPES, JC ;
HAHN, BH ;
SHAW, GM .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (14) :954-960
[7]   INCREASED VIRAL BURDEN AND CYTOPATHICITY CORRELATE TEMPORALLY WITH CD4+ T-LYMPHOCYTE DECLINE AND CLINICAL PROGRESSION IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED INDIVIDUALS [J].
CONNOR, RI ;
MOHRI, H ;
CAO, YZ ;
HO, DD .
JOURNAL OF VIROLOGY, 1993, 67 (04) :1772-1777
[8]  
FENYO EM, 1988, J VIROL, V62, P4414
[9]   HIV-1 VARIABILITY AND PROGRESSION TO AIDS - A LONGITUDINAL-STUDY [J].
FIORE, JR ;
CALABRO, ML ;
ANGARANO, G ;
DEROSSI, A ;
FICO, C ;
PASTORE, G ;
BIANCHI, LC .
JOURNAL OF MEDICAL VIROLOGY, 1990, 32 (04) :252-256
[10]   BIOLOGICAL CHARACTERIZATION OF INFECTIOUS MOLECULAR CLONES DERIVED FROM A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATE WITH RAPID/HIGH REPLICATIVE CAPACITY [J].
FREDRIKSSON, R ;
STALHANSKE, P ;
VONGEGERFELT, A ;
LIND, B ;
AMAN, P ;
RASSART, E ;
FENYO, EM .
VIROLOGY, 1991, 181 (01) :55-61